- 27 November, 2024
Takeaways and reviews, what went down during Miami Tech Week
Miami Tech Week took place last week in the South Florida city as part of April’s Tech Month programming, which also included NFT Miami and
This computer software stock is trading up in after-hours
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Elon Musk buys Twitter: expert reveals potential regulatory delays ahead
Elon Musk has succeeded in buying Twitter Inc (NYSE: TWTR). The social media and microblogging company confirmed just moments ago that its board, after a
Snowflake stock price forecast: Wolfe Research sees a 45% upside
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Law Decoded: Competing narratives around crypto clash on the Earth Day, April 19-26
Regulation by enforcement, a fast and economical substitute for thorough rulemaking, is widely regarded as some of the U.S. executive agencies’ preeminent approach to crypto
Price analysis 4/25: BTC, ETH, BNB, XRP, SOL, LUNA, ADA, AVAX, DOGE, DOT
Bitcoin (BTC) continues to trade below $40,000 as bears try to flip the level into resistance. The soaring U.S. dollar index (DXY), which is usually
Pro: these companies with growing gross profit look attractive
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
New York legislators to vote on PoW mining moratorium this week
The New York state legislature might ban Proof-of-Work (PoW) crypto mining in the state for at least two years, citing environmental concerns. Over the past
US stocks look to bounce after early sell-off pressure
US stocks fell in early trades on Monday as negative sentiment across global equities intensified. After closing sharply lower last week, US indexes extended losses
Here is why Nkarta is 40% up
Nkarta Inc. (NASDAQ: NKTX) is up 40% after announcing positive preliminary Phase 1 findings from its dose-finding trials of NKX101 and NKX019 in hematological malignancies.